Press release
Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market to Register Substantial Expansion by 2024
Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons. Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles. Hence, it is widely targeted for therapeutic treatments of Parkinson’s and Huntington’s disease. VMAT2 inhibitors block VMAT2 proteins and control the neurotransmission activity, thereby reducing the unwanted body movements caused by Huntington’s disease and tardive dyskinesia.VMAT2 inhibitors are widely used for the treatment of uncontrollable involuntary, repetitive body movements caused due to tardive dyskinesia and Huntington’s disease.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37724
The global vesicular monoamine transporter-2 inhibitors market is driven primarily by rise in incidence of the diseases mentioned above. Huntington’s disease is a progressive brain disorder that causes involuntary body movement, loss of recognition ability, and emotional problems. Prevalence of this disease is high in the developed countries, especially in Europe. An estimated five to seven people per 100,000 are affected by Huntington’s disease in countries in the West. High prevalence of Huntington’s disease has been observed in Venezuela, where around 700 people per 100,000 have the disease. Tardive dyskinesia is a side effect of antipsychotic medications used for the treatment of schizophrenia and other mental health disorders. In the U.S., this disease occurs in 15% to 30% patients who have received long-term neuroleptic medication. Moreover, the investigational studies for the discovery of novel therapeutics using VMAT2 inhibitor to treat methamphetamine abuse are likely to boost demand during the forecast period. However, side effects of VMAT 2 inhibitors such as sleepiness, dry mouth, constipation, and heart conduction changes are likely to hamper the growth of the VMAT2 inhibitors market.
Request for Analysis of COVID19 Impact on Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=37724
The global VMAT2 inhibitors market can be segmented based on application and region. In terms of application, the global market can categorized into Huntington’s disease and tardive dyskinesia. The tardive dyskinesia segment is projected to account for high market share by 2025. The segment is anticipated to record exponential growth rate during the forecast period. People with schizophrenia, bipolar disorders, and other neuropsychiatric disorders undergoing long-term medical treatments with antipsychotic medication are more likely to develop symptoms of tardive dyskinesia.
Pre-Book Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=37724<ype=S
Geographically, the global VMAT2 inhibitors market can be segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World. North America is expected to hold significant share of the global market by 2025. Large market share of the region is attributed to increase in number of patients with bipolar diseases, schizophrenia, and Huntington’s disease in this region. Europe is likely to record high CAGR during the forecast period. High prevalence of Huntington’s disease and rise in incidence of tardive dyskinesia are projected to drive the market in the region during the forecast period. The market in Asia Pacific is anticipated to expand at a moderate growth rate during the forecast period.
Key players operating in the global VMAT2 inhibitors market include Tocris Bioscience, Neurocrine Biosciences, Inc., Teva Pharmaceuticals Industries Ltd., EUSA Pharma (UK) Limited, and Lundbeck, Inc.
Read More Reports: https://www.prnewswire.com/news-releases/growing-need-to-effectively-manage-increasing-burden-of-diabetes-to-propel-diabetes-devices-market-forward-tmr-301097980.html
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market to Register Substantial Expansion by 2024 here
News-ID: 2153426 • Views: …
More Releases from Transparency Market Research

Point-of-Care Glucose Testing Market: Technological Innovations Shaping the Futu …
The global healthcare industry is undergoing a technological revolution, and Point-of-Care (POC) glucose testing is at the forefront of this transformation. As diabetes continues to impact millions of lives worldwide, the need for efficient, accurate, and timely glucose monitoring has become critical.
Newly released data from Transparency Market Research reveals that the global POC glucose testing market was valued at USD 3.7 billion in 2021 and is expected to reach USD…

Dental Dust Collector Market: Regional Insights and Forecasts to 2031
The dental dust collector market has been witnessing significant growth as the dental industry places a greater emphasis on occupational safety and adopts advanced technology.
Dental dust collectors play a crucial role in creating a clean and safe environment in dental clinics and laboratories by capturing harmful airborne particles produced during procedures such as drilling, grinding, and polishing.
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85310
These devices…

Vacuum Insulation Panels Market Size Will Anticipated to Reach US$ 12.6 Billion, …
The vacuum insulation panels (VIPs) market represents a vital component in the global push for energy efficiency and thermal insulation solutions. VIPs are advanced thermal insulating materials that offer superior performance compared to traditional insulation products. These panels, composed of a core material enclosed within a gas-tight envelope, are widely used across industries, including construction, refrigeration, and logistics, where high thermal resistance is critical.
It is estimated to grow at a…

Aviation Lubricants Market Outlook 2031: Expanding from US$ 991.8 Million to US$ …
The aviation lubricants market is a crucial segment within the aerospace industry, encompassing specialized oils, greases, and fluids designed to enhance the performance and reliability of aircraft systems. These lubricants are essential for ensuring operational efficiency, reducing wear and tear, and maintaining safety standards across commercial, military, and general aviation sectors.
It is estimated to grow at a CAGR of 5.4% from 2023 to 2031 and reach US$ 1.6 Bn by…
More Releases for VMAT
SWOT Analysis of Radiotherapy Market 2018: Key Players Are RaySearch Laboratorie …
Global Radiotherapy Market Research Report is a professional and in-depth study on the current state of the Global Radiotherapy Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Radiotherapy analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Click Here for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiotherapy-market
New report title “Global Radiotherapy…
Europe Radiotherapy Market
The Europe Radiotherapy Market research report consists of a primary and secondary research along with an in-depth analysis of the quantitative and qualitative aspects by the expert industry analysts and professionals, leading management bodies, to gain a profound insight of the industry as well as the industry performance. The Europe Radiotherapy Market report presents a lucid picture of the current industry landscape, including the historical and projected market size, based…
Europe Radiotherapy Market Seeing Robust Growth Dominated With Expected +6.7% CA …
Radiotherapy/Radiation therapy is a treatment used for cancer and, less commonly, thyroid disease, blood disorders, and noncancerous growths, Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to…
Radiotherapy Market 2024: Analysis By Types, Industry Top Players, Regions & Mar …
Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024.
New report title “Global Radiotherapy Market, By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast…
Asia Pacific (APAC) Radiotherapy Market Analysis 2017-2024: Varian Medical Syste …
APAC Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (China, India, Japan, South Korea, Singapore, Australia, Rest of APAC) and Forecast to 2024
APAC Radiotherapy Market has accounted for USD 1.1 billion in 2016, and is expected to…
Radiotherapy Market Professional Survey 2024 Global Industry Growth Forecast Res …
databridgemarketresearch.com added new report title “Global Radiotherapy Market, By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Geography (North America, Europe, Asia Pacific, South America, Rest of the World)” – Industry Trends and Forecast to 2024
Click Here for Free Sample Report @…